Summit Therapeutics (SMMT) Q3 2026 Earnings Report

1 Followers

MX:SMMT Upcoming Earnings

Summit Therapeutics's next earnings date is estimated for March 18, 2027, based on past reporting schedules.

Q3 2026 Earnings Call Summary

No earnings call summary is available for this earnings event.

MX:SMMT earnings history
Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change	Press Release
Mar 18, 2027	2026 (Q4)	-5.52-	-5.39	―	―
Nov 04, 2026	2026 (Q3)	-5.25-4.84	-5.77	16.13% (+0.93)
Jul 23, 2026	2026 (Q2)	-5.10-5.21	-14.14	63.16% (+8.93)
Apr 30, 2026	2026 (Q1)	-5.00-4.46	-1.67	-166.67% (-2.79)
Feb 23, 2026	2025 (Q4)	-1.43-5.39	-1.49	-262.50% (-3.91)
Oct 20, 2025	2025 (Q3)	-1.56-5.77	-1.49	-287.50% (-4.28)
Aug 11, 2025	2025 (Q2)	-1.69-14.14	-0.93	-1420.00% (-13.21)
May 01, 2025	2025 (Q1)	-1.73-1.67	-1.12	-50.00% (-0.56)
Feb 24, 2025	2024 (Q4)	-1.53-1.49	-0.93	-60.00% (-0.56)
Oct 30, 2024	2024 (Q3)	-1.25-1.49	-0.56	-166.67% (-0.93)
Aug 06, 2024	2024 (Q2)	-1.15-0.93	-0.39	-138.10% (-0.54)
May 01, 2024	2024 (Q1)	-1.12-1.12	-26.6	95.80% (+25.48)
Feb 20, 2024	2023 (Q4)	―-0.93	-1.3	28.57% (+0.37)
Nov 07, 2023	2023 (Q3)	―-0.56	-2.6	78.57% (+2.05)
Aug 09, 2023	2023 (Q2)	―-0.39	-3.16	87.65% (+2.77)
May 11, 2023	2023 (Q1)	―-26.60	-4.09	-550.00% (-22.51)
Mar 09, 2023	2022 (Q4)	―-1.30	-5.21	75.00% (+3.91)
Nov 09, 2022	2022 (Q3)	―-2.60	-3.72	30.00% (+1.12)
Aug 11, 2022	2022 (Q2)	―-3.16	-5.02	37.04% (+1.86)
May 11, 2022	2022 (Q1)	―-4.09	-3.91	-4.76% (-0.19)
Mar 17, 2022	2021 (Q4)	-5.02-5.21	-3.35	-55.56% (-1.86)
Nov 15, 2021	2021 (Q3)	-5.39-3.72	-4.84	23.08% (+1.12)
Aug 11, 2021	2021 (Q2)	-3.35-5.02	-4.28	-17.39% (-0.74)
May 17, 2021	2021 (Q1)	―-3.91	-0.37	-950.00% (-3.53)
Mar 17, 2021	2020 (Q4)	―-3.35	-0.71	-373.68% (-2.64)
Nov 16, 2020	2020 (Q3)	―-4.84	-0.93	-420.00% (-3.91)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed